| VCEL Snapshot | |
|---|---|
| Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cell therapies for the sports medicine and severe burn care markets in the United States. The company is headquartered in Cambridge, Massachusetts. | |
| VALUATION DATA | |
| Market Capitalization | $2,299,041,000 | Price to Sales | 0.00 |
| Earnings per Share | $-0.0700 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $46.2600 |
| 52 Week High | $11.73 |
| 52 Week Low | $10.26 |
| 50-Day Moving Average | $11.62 |
| 200-Day Moving Average | $801.64 |
| All data are from Alpha Vantage as of today. For more infomation on VCEL see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search